Postmenopausal women with a diverse gut microbiome have higher levels of estrogen metabolites.
The percentage of women that underwent a double mastectomy increased substantially between 1998 and 2011, even though the procedure was not associated with a lower risk of death than breast-conserving surgery plus radiation.
Women with severe disabilities and multiple chronic conditions are screened for breast cancer less often than women with no disabilities or no chronic conditions.
GP2, a novel immunotherapy, has demonstrated a reduction in recurrence in patients with breast cancer.
Researchers have developed a new integrated approach to identify the genetic drivers of cancer, uncovering eight genes necessary for cell proliferation in breast cancer.
Study raises questions about the effect of soy's estrogen-like properties.
Women overdue for mammogram respond better to postcard plus reminder letter from family physician.
A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to new research.
Evidence-based recommendations have been developed for chemotherapy and targeted therapy for women with HER2-negative advanced breast cancer.
Celebrity story helped double rates of genetic testing in following six months at one cancer center.
Women with breast cancer who have a double mastectomy are at higher risk of certain complications than those who have a single mastectomy, though the overall complication rate associated with breast cancer surgery is small.
Wearing bras does not increase a woman's risk for developing breast cancer.
This fact sheet examines the potential pros and cons of surgery as a means to reduce breast cancer risk.
Following a mastectomy, less than 42% of women underwent breast reconstruction, and the factors associated with foregoing reconstruction included being black, being less educated, and being older.
Survey of women with breast cancer explores factors in the decision to remove a healthy breast as a measure to prevent breast cancer.
Bilateral mastectomy-linked mortality rates are up for women diagnosed with stage 0 to III breast cancer.
Despite an increase in double mastectomy for early-stage breast cancer, the procedure does not reduce the risk of mortality.
A biomarker strongly linked to basal-like breast cancer has been identified.
This recently published study found strong evidence linking physical exercise to a lower rate of breast cancer in African American women, a group in which previous evidence has been lacking.
Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study.
Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study.
Postmenopausal women who in the past 4 years had undertaken regular physical activity equivalent to at least 4 hours of walking per week had a lower risk for invasive breast cancer compared with women who exercised less
The PALB2 gene is potentially one of the most important genes associated with breast cancer after the BRCA1/2 genes.
Recurrence of hormone-related breast cancer was reduced by 50% in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), according to newly published data.
Dasatinib shows promise for treating skin, breast and several other cancers.
MRI detects 18.1 additional cancers after negative findings with mammography and ultrasonography per 1,000 women.
Data from two randomized controlled trials suggest that bisphosphonate use does not protect against postmenopausal breast cancer, according to research.
In overweight women, aspirin or other drugs might make certain breast cancers more treatable.
Writing down fears, emotions, and the benefits of a cancer diagnosis may improve health outcomes for Asian American survivors of breast cancer, according to a new study. The research investigated methods of reducing the psychological burden among minority patients, particularly among breast cancer survivors.
New research suggests that cancer would be more accurately diagnosed in 1 of every 10 patients if their tumors were defined by cellular and molecular criteria rather than by the tissues in which they originated, and that this information, in turn, could lead to more appropriate treatments.
Mammography-detected breast cancer is associated with a shift to earlier stage diagnosis in older women, subsequently reducing the rate of more advanced, difficult-to-treat cases. Researchers said the findings lend support to regular mammography screening in women age 75 years and older.
Mutations in PALB2 and germline mutations in the multiple endocrine neoplasia type 1 (MEN1) tumor-suppressor gene causing MEN1 correlate with increased breast cancer risk, according to two studies.
Electroacupuncture (EA) produces significant improvements in fatigue, anxiety, and depression in as little as 8 weeks for patients with early stage breast cancer experiencing joint pain related to the use of aromatase inhibitors to treat breast cancer.
Older women intent on keeping breast cancer at bay may want to start and maintain a regular exercise regimen.
Breast cancer survival has been found to be better in women whose cancer was detected by mammography.
Electroacupuncture may reduce comorbid symptoms of pain in women with breast cancer who have aromatase inhibitor-related arthralgia, according to research.
Research published in the Journal of Biomedicine and Biotechnology suggests that ginger may be a promising breast cancer treatment.
Women who recently used birth control pills containing high-dose estrogen and a few other formulations had an increased risk for breast cancer, whereas women using some other formulations did not, according to recent data.
A gel form of tamoxifen applied to the breasts of women with noninvasive breast cancer reduced the growth of cancer cells to the same degree as the drug taken in oral form but with fewer side effects.
According to a study published in Radiology, women over 75, a population not typically included in mammography screening effectiveness studies, may benefit from mammograms.
A new molecular analysis tool accurately detected the level of an important target for immunotherapy in early stage breast cancers.
A new study demonstrated that writing about emotionally difficult events, such as a cancer diagnosis, might improve outcomes for some breast cancer survivors.
Keeping a light on at night can suppress the body's production of a hormone called melatonin, possibly reducing the effectiveness of the breast-cancer drug tamoxifen, a study suggests.
For rats bearing human breast tumors, exposure to dim light at night made the tumors resistant to the breast cancer drug tamoxifen, according to recently published data.
A team of researchers from Boston University School of Medicine sought to determine the impact of patient navigators on the care of low-income and African-American women with breast cancer.
Use of electroacupuncture produces significant improvements in fatigue, anxiety, and depression in as little as 8 weeks for patients with early stage breast cancer patients experiencing joint pain related to the use of AIs to treat breast cancer.
A new study has identified three genetic changes in East Asian women linked to an increased risk of breast cancer.
Breast cancer screening is once again controversial. In this editorial, the author discusses new research demonstrating the effectiveness of an MRI imaging technique called first postcontrast subtracted T1-weighted image (FAST).
What is the preferred delivery protocol for breast cancer adjuvant bisphosphonates?
A study of people who were adopted identified genetics as the dominant risk factor in familial breast, prostate, and colorectal cancers.
Breast cancer screening costs for Medicare patients skyrocketed between 2001 and 2009, but the increase did not lead to earlier detection of new breast cancer cases, according to a study.
A new study suggests a safe and effective role for natural steroid hormones in treating postmenopausal breast cancer, with fewer detrimental side effects and improved health profile than with standard antihormone therapies.
A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, even in the absence of a high-risk BRCA1 gene mutation, according to new research.
Researchers have identified genes that may help predict whether a patient with estrogen receptor (ER)-positive breast cancer is likely to benefit from tamoxifen therapy.
Circulating tumor cells captured with a microchip-based device can be cultured to establish cell lines for genetic analysis and drug testing.
Current studies indicate that the levels of parabens used in cosmetics are safe (typical levels are 0.1% to 0.3%); however, many believe a relationship to cancer exists, particularly breast cancer. The furor came about after a 2004 study reported finding parabens in the breast tissue of 20 women.
New findings paint a relatively optimistic picture of women's chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond.
The era of personalized medicine for breast cancer may be just around the corner, thanks to recent advances by USC Stem Cell researcher Min Yu and scientists at Massachusetts General Hospital and Harvard Medical School.
Researchers have created a microchip device that can capture circulating tumor cells, in order to track ongoing genetic mutation within a tumor.
Using an innovative tool that captures heretofore hidden ways that cells are regulated, scientists have identified a protein that makes breast cancer cells more likely to metastasize.
Although use of newer technologies and costs associated with breast cancer screening have increased, no change in stage at diagnosis has been observed in Medicare beneficiaries.
A gel containing the drug tamoxifen and applied to the skin was as effective as the pill form in reducing the growth of breast cancer cells in women with noninvasive cancer.
In the 30 years since mammography was introduced, late-stage breast cancer incidence has decreased by 37%, according to a new study. The analysis, from the University of Michigan Comprehensive Cancer Center in Ann Arbor, takes into account an observed underlying trend of increased breast cancer incidence present since the 1940s
New findings from Fox Chase Cancer Center paint a relatively optimistic picture of women's chances of surviving a subset of breast cancers that have spread to the chest wall or skin.
A microchip-based device developed at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine and the MGH Cancer Center can capture circulating tumor cells (CTCs). The CTCs can then be cultured to establish cell lines for genetic analysis and drug testing.
A compound initially developed as a treatment for high cholesterol not only halts the progression of breast cancer, but also can kill cancer cells.
The presence of hyperlipidemia has been linked to 1.64-fold increased risk of breast cancer.
Barriers to obtaining gene expression profiling tests increased their perceived importance among patients with early breast cancer (estrogen-receptor positive [ER+], human epidermal growth-factor receptor 2 negative [HER2-], and node negative) who were deciding whether to have chemotherapy after surgery, according to a new study from Canada.
Study findings from Fox Chase Cancer Center offer relatively optimistic news for women with breast cancer whose disease has spread to the chest wall or skin, but not beyond.
A new study has found that the levonorgestrel-releasing intrauterine system, or progesterone-releasing IUD, may be associated with a higher than expected incidence of breast cancer.
A series of simple telephone calls can make a profound difference in helping women with breast cancer to meet their treatment goals for weight loss.
A recent study of HER2 testing in a large cohort of women with breast cancer found important limitations in testing methods.
The fight against breast cancer is never-ending, but Virginia Tech researchers have found additional diagnostic markers that may aid clinicians to better forecast and prevent the disease.
The more sugary drinks a woman consumes, the greater her risk for breast cancer, a study has found.
Massachusetts legislators introduced a bill that requires doctors to tell patients when a mammogram reveals that the woman has breast dense tissue.
The use of new technique, which includes four approaches, could reduce unnecessary breast biopsies.
High cholesterol levels may increase a woman's risk of developing breast cancer, a large new British study reports.
Many patients older than 65 years with localized breast cancer are eligible for adjuvant hormonal therapy, but little is known about why patients start and stop treatment.
A new systematic review shows that treatment with the breast cancer drug trastuzumab is associated with prolonged survival in women with advanced breast cancer, but the risk of developing heart problems also increases.
In a comparison of data from 2001-2002 and 2008-2009, the use of screening mammography for Medicare-enrolled women without a history of breast cancer was consistent, at approximately 42%. However, the increase in use of more expensive digital mammography technology has resulted in higher costs ($115 vs $73 per mammogram).
New research presents another cause for concern in regard to the chemical bisphenol A (BPA). The study is the first to examine what impact BPA has on the DNA of mammary glands as they age.
Medicare's mammography costs increased by almost 50% over a 7-year period while the breast cancer detection rate and stage at diagnosis did not change, according to a study.
A study from the University of Texas MD Anderson Cancer Center reveals a disparity in use of sentinel lymph node biopsy between black and white women.
Imaging breast tumors using four approaches together can better distinguish between malignant breast tumors and those that are benign, compared with imaging using fewer approaches.
The antimalarial drug hydroxychloroquine (HCQ) reverses resistance to tamoxifen in mice, according to investigators.
Scientists have discovered that a gene previously linked to leukaemia could provide an urgently needed target for the development of drugs to treat patients with 'triple negative' breast cancer.
Compared with digital mammography alone, the combination of digital mammography and tomosynthesis increases cancer detection and reduces false-positive results, according to research.
What is the best approach to learning more about the field of Radiation Oncology?
Since mammography was introduced late-stage breast cancer incidence has decreased by 37%, according to a new study
African-American women frequently present with biologically less favorable subtypes of breast cancer, according to a research study.
A study has revealed that the gene Metadherin—which is implicated in promoting the spread of breast cancer tumors—only stimulates tumor growth when the protein made by the gene interacts with a second protein.
A recent innovation in breast cancer biomarkers seeks to visualize the HER3 receptor, which could mean more comprehensive breast cancer imaging and potential treatments.
Although they experienced classic symptoms of post-surgical lymphedema, many breast patients didn't recognize the condition as related to treatment.
Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent when undergoing lymphoscintigraphy.
Majority of BRCA mutation carriers opted for different surgery than initially planned by surgeon.
Reducing carbohydrate intake could reduce the risk of breast cancer recurrence among women whose tumor tissue is positive for the insulin-like growth factor-1 (IGF1) receptor, according to a new study.
A chemical commonly used in plastics, appears to increase the proliferation of breast cancer cells, according to Duke Medicine researchers.
Among postmenopausal women receiving letrozole as adjuvant therapy for breast cancer, a telephone-based weight loss intervention was effective in promoting weight loss.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|